The SA Health Products Regulatory Authority (Sahpra) said on Tuesday  it had approved a “section 21” emergency use application for the Covid-19 vaccine developed by Pfizer and BioNTech. The country’s drugs regulator said  the approval was subject to further efficacy and safety surveillance of the vaccine in the country, including against the dominant local coronavirus variant. - Reuters